-+ 0.00%
-+ 0.00%
-+ 0.00%

Pasithea Therapeutics Q3 EPS $(0.41) Up From $(2.87) YoY

Benzinga·11/13/2025 22:34:58
Listen to the news
Pasithea Therapeutics (NASDAQ:KTTA) reported quarterly losses of $(0.41) per share. This is a 85.71 percent increase over losses of $(2.87) per share from the same period last year.